Painless thyroiditis-induced acute myocardial infarction with normal coronary arteries
Contents lists available at ScienceDirect
American Journal of Emergency Medicine
journal homepage: www. elsevier. com/ locate/ajem
American Journal of Emergency Medicine 33 (2015) 983.e5-983.e10
Painless thyroiditis-induced acute myocardial infarction with Normal coronary arteries?,??
Acute myocardial infarction (AMI) is a common life-threatening dis- ease in the emergency department. However, it is rare that AMI is induced by painless thyroiditis in an individual with normal coronary arteries. Here, we describe a very rare case of thyroiditis-induced AMI and review the literature concerning patients with thyrotoxicosis-related AMI.
A 21-year-old man, without a history of Tobacco use, recreational drug abuse, or inherited Cardiovascular risk factors, presented with a sudden onset of chest pain when he slept. Three days prior, he had experienced a similar chest pain after drinking alcohol, which spontane- ously relieved after a few minutes. On presentation, his heart rate was 95 beats per minute, and blood pressure was 168/82 mm Hg. Marked ST-segment elevation in II, III, aVF, and V7 to V9 was found on electro- cardiogram (ECG) (Fig. 1). Levels of troponin I rose to 11.1 ng/mL and Creatine phosphokinase (CK)-MB to 27.70 ng/mL (Fig. 2). However, echocardiography showed no wall-motion abnormalities or ventricle dysfunction (ejection fraction, 54%). emergency coronary angiography revealed normal coronary arteries with no sign of coronary dissection or atherosclerosis (Fig. 3; Videos 1 and 2). No further procedures were implemented, and medical treatment was chosen.
The patient had no clinical or biological signs suggestive of myocar- ditis, myocardial bridging, early repolarization syndrome, Behcet disease, lupus erythematosus, Antiphospholipid syndrome, or Takayasu disease. Upon 2 days’ complaining of persistent palpitation (~ 95-110 beats per minute) and tremor, the patient was subjected to thyroid function testing. The test revealed thyrotoxicosis, but the titers for antithyrotropin receptor and thyroid-stimulating antibody were negative (Table). Thyroid ultrasound showed a smooth thyroid without focal lesions. A technetium Tc 99m pertechnetate scan indicated markedly low thyroid uptake, compatible with thyroiditis. We diag- nosed the patient with painless thyroiditis (thyrotoxic phase) and con- cluded that thyrotoxicosis had induced Coronary vasospasm, resulting in AMI. The patient was treated with diltiazem and propranolol. He did not report any chest pain during the 24-month follow-up period.
Thyrotoxicosis alters the cardiovascular hemodynamics by increasing the heart rate, cardiac contractility, and cardiac output and by decreasing systemic vascular resistance [4,5]. In this way, thyrotoxicosis increases the risk of angina pectoris and AMI by coronary vasospasm. Angina is a com- mon symptom in patients with hyperthyroidism; however, AMI, as oc- curred in our patient, is infrequently observed [1,3]. Our patient was first diagnosed with AMI, but the coronary angiographic results showed no signs of stenosis, occlusion, or atherosclerotic changes. Thus, we ex- cluded the possibility of thrombolytic myocardial infarction and assumed
? Conflict of interest: No conflict of interest.
?? Patient consent: Obtained.
that the symptoms were caused by a temporary coronary vasospasm. Subsequent tests suggested that the spasm could be induced by thyro- toxicosis associated with painless thyroiditis (thyrotoxic stage).
Painless thyroiditis, accounting for approximately 0.5% to 5% of all thy- rotoxicosis cases, is diagnosed by increased free T4 and free T3 levels for less than 3 months and/or later development of transient hypothyroidism without neck pain or tenderness [6,7]. This condition is caused by the destruction of thyroid follicles and the release of excess thyroid hormones into the circulation. Painless thyroiditis often manifests as transient thyro- toxicosis and displays symptoms similar to those of Graves disease. The combined application of thyroid function test, thyroid antibodies test, and scintigraphy is helpful in the differential diagnosis [2,8,9].
We reviewed all 21 AMI patients (including our patient) with thyro- toxicosis/thyroiditis who have been reported in the English literature since 2000 (Table). Most cases (15/21) presented between the ages of 20 and 60 years (mean age, 47 years), with a female predominance (female: male, 14:7). Patients usually had severe, persistent chest pain with onset at rest. Associated symptoms included arrhythmias (sinus tachycardia and atrial fibrillation), dyspnea, and sudden cardiac death. Approximately 25% of patients exhibited palpitation, tremor, or other hyperthyroid-state symptoms. A thyroid medical history or recent weight loss was valuable diagnostic clues in 6 of 21 patients. The physical examination was similar to that of other patients with AMI. A goiter or thyroid eye signs were sometimes found. Initial ECG manifested as typical AMI changes, but initial angiography often revealed normal coronary arteries (13/21) or coronary vasospasm (3/21) without thrombolytic occlusion. Patients were diagnosed with Graves disease (8/21), subclinical hyperthyroidism (6/21), painless thyroiditis (3/21), iatrogenic thyrotoxicosis (2/21), and postoperational thyrotoxicosis (1/21). Thyroid function and thyroid uptake of technetium Tc 99m provide evidence for diagnosis. ?-Blocker was the first choice of therapy in most patients, given the combination of AMI with thyrotoxicosis; however, nitrates and calcium antagonists should be considered because coronary vasospasm is also present. Symptoms were often self-limiting with excellent prognosis (18/21). Recurrent angina (1/21) or death (2/21) occasionally occurred.
In conclusion, thyrotoxicosis, especially induced by painless thyroid- itis, should be considered when patients manifest with typical AMI but with normal angiographic results and no cardiovascular disease risk factors. Age; sex; medical history; state of onset; characteristic symp- toms and signs; and unexplainable arrhythmia, such as sinus tachycar- dia or atrial fibrillation, could provide valuable diagnostic clues. We suggest that routine thyroid function tests should be performed for AMI patients with normal angiogram.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ajem.2014.12.071.
0735-6757/(C) 2015
983.e6 W. Zheng et al. / American Journal of Emergency Medicine 33 (2015) 983.e5–983.e10
Fig. 1. Evolution of ECG. A, The ECG on admission showed ST-segment elevation of lead II, III, aVF, and V7 to V9, diagnosed as an acute inferior and posterior myocardial infarction. B and C, A typical evolution of acute myocardial infarction including ST-segment resolution and Q-wave formation.
W. Zheng et al. / American Journal of Emergency Medicine 33 (2015) 983.e5–983.e10 983.e7
Fig. 2. Changes in cardiac troponin I and CK-MB after admission. The evolution of cardiac enzymes was generally in accordance with changes typical of AMI. Earlier peak and quicker res- toration to normal level were observed because of less myocardial injury caused by spasm. Reference ranges of cardiac enzymes are as follows: cardiac troponin I, less than 0.034 ng/mL; CK-MB, less than 3.38 ng/mL.
Fig. 3. coronary angiogram. A and B, Normal coronary arteries were observed on angiogram.
The authors thank Medjaden Bioscience Limited for assisting in the preparation of this manuscript.
Wen Zheng, MD, PhD Yu-Jiao Zhang, MD, PhD Shu-Yan Li, MD, PhD
Department of Cardiology, the First Hospital of Jilin University, Changchun, China
E-mail addresses: [email protected] [email protected], [email protected]
Lu-Lun Liu, MD
Thyroid Surgery Department, the First Hospital of
Jilin University, Changchun, China E-mail address: [email protected]
Jian Sun, MD, PhD Department of Cardiology, the First Hospital of Jilin University, Changchun, China
Corresponding author. Department of Cardiology the First Hospital of Jilin University, Changchun, China, 130021. Tel.: +86-13943085420
E-mail address: [email protected] http://dx.doi.org/10.1016/j.ajem.2014.12.071
983.e8
Summary of reported patients with thyrotoxicosis-induced AMI since 2000
W. Zheng et al. / American Journal of Emergency Medicine 33 (2015) 983.e5–983.e10
Author |
Year |
Age |
Sex |
Angiograpic findings |
Arrhythmia |
Characteristic symptoms and signs/thyroid medical history |
Diagnosis |
TSH level (uUI/mL) |
Free T3 (pg/mL) |
Free T4 (ng/dL) |
Treatment |
Follow-up |
Outcomes |
Current study |
2014 |
21 |
M |
Normal coronary |
Sinus |
Palpitation and |
Painless thyroiditis |
0.034 |
7.21 |
33.76 |
Aspirin, clopidogrel, |
24 mo |
Normal thyroid |
Zheng et al [1] |
2014 |
26 |
M |
arteries Normal coronary |
tachycardia Sinus |
tremor NA/medical history |
Painless thyroiditis |
NA |
NA |
NA |
isosorbide dinitrate, diltiazem, and propranolol Aspirin, clopidogrel, |
1 mo |
function & well Asymptomatic |
Bouabdallaoui |
2013 |
23 |
F |
arteries and myocardial bridging over LAD Normal coronary |
tachycardia NA |
NA |
Graves disease |
b0.005 |
NA |
NA |
and isosorbide dinitrate NA |
3 mo/3 y |
Thrombus |
et al [2] |
arteries and distal |
disappearance/ |
|||||||||||
Patane et al [10] |
2012 |
75 |
F |
LAD thrombosis Normal coronary |
AF |
NA/medical history |
Subclinical |
0.003 |
2.77 |
1.53 |
NA |
NA |
well NA |
Lee et al [11] |
2012 |
48 |
F |
arteries Normal coronary |
NA |
NA |
hyperthyroidism Graves disease |
0.031 |
26 |
NA |
Carbimazole, isosorbide |
2 mo/1.5 |
Normal thyroid |
Kauffels et al |
2012 |
55 |
F |
arteries Normal coronary |
Sinus |
NA/medical history |
Thyrotoxicosis after |
0.04 |
11.4 |
5.15 |
dinitrate, nifedipine Ivabradine, |
y NA |
function/ well NA |
Hama et al [13] |
2012 |
25 |
F |
arteries Left coronary |
tachycardia Tachycardia |
Cardiopulmonary |
parathyroidectomy Subclinical |
b0.03 |
10.5 |
1.89 |
parathyroidectomy NA |
NA |
Died |
Kim et al [3] |
2011 |
35 |
M |
Artery thrombosis (autopsy) Normal coronary |
NA |
arrest/medical history NA |
hyperthyroidism Painless thyroiditis |
0.04 |
NA |
4.51 |
Diltiazem, isosorbide |
12 mo |
Normal thyroid |
Patane et al [14] |
2010 |
78 |
M |
arteries Severe 3 vessels |
AF |
NA |
Subclinical |
0.068 |
2.07 |
1.06 |
dinitrate NA |
NA |
function NA |
Lewandowski |
2010 |
31 |
F |
diseases Spasm of LAD and |
Tachycardia |
Palpitation and |
hyperthyroidism Graves disease |
0.02 |
3.24 |
12.78 |
Thiamazole |
18 mo |
Normal thyroid |
et al [15] |
narrowing of LAD |
tremor |
function |
||||||||||
Patane et al [16] |
2010 |
90 |
M |
apical segment NA |
AF |
NA |
Subclinical |
0.071 |
1.66 |
NA |
NA |
NA |
NA |
hyperthyroidism |
Patane et al [17] |
2010 |
63 |
M |
Normal coronary arteries |
AF |
Palpitation |
Subclinical hyperthyroidism |
0.082 |
3.14 |
1.20 |
NA |
NA |
NA |
Iwanczuk [18] Patane et al [19] |
2010 2009 |
51 28 |
F M |
NA Normal coronary |
NA NA |
Cardiogenic shock NA/ medical history |
Iatrogenic |
0.009 0.008 |
4.71 8.17 |
13.73 NA |
inotropic support, thiamazole, ?-blockers, iodine solution, glucocorticoids, and diuretics Aspirin, Intravenous heparin, |
NA NA |
NA NA |
arteries and myocardial bridging over the LAD |
hyperthyroidism |
nitroglycerin, tirofiban |
|||||||||||
Patane et al [20] Patel et al [21] |
2009 2008 |
67 40 |
F F |
Normal coronary arteries Ostial spasm of |
PST/AF Tachycardia |
NA Weight loss |
Subclinical hyperthyroidism Graves disease |
0.009 b0.1 |
3.04 NA |
1.4 3.7 |
Aspirin, intravenous heparin, nitroglycerin, tirofiban, clopidogrel, bisoprolol Isosorbide dinitrate, |
NA 4 mo/1 y |
NA Normal thyroid |
Chudleigh et al |
2007 |
36 |
F |
LM and RCA Left main |
Tachycardia |
Goiter with bruit, |
Graves disease |
b0.02 |
NA |
32.7 |
metoprolol, and methimazole Propylthiouracil, propranolol, |
6 wk |
function/ recurrent angina with elevated fT4 Normal thyroid |
Chudleigh et al |
2007 |
59 |
F |
stem stenosis Normal coronary |
NA |
tremor and ophthalmopathy/ medical history Goiter |
Graves disease |
b0.02 |
NA |
12.59 |
warfarin, and radioactive iodine Carbimazole, diltiazem, and conventional |
NA |
function NA |
Gowda et al [23] |
2003 |
51 |
F |
arteries Normal coronary |
NA |
NA/medical history |
Iatrogenic |
b0.01 |
2.43 |
2.3 |
cardiac treatment Standard anti-ischemic |
4 mo |
Asymptomatic |
Lassnig et al |
2003 |
66 |
F |
arteries Total occlusion of |
NA |
Hyperthyroid state |
hyperthyroidism Graves disease |
0.01 |
6.48 |
43.6 |
therapy and levothyroxine Thiamazol, nitrates, anesthetized and |
At |
Died |
Timurkaynak |
2002 |
28 |
F |
LAD and LCX due to vasospasm Normal coronary |
Tachycardia |
NA |
Graves disease |
0.01 |
14.83 |
5.1 |
mechanically ventilated Propylthiouracil, ?-blocker, and |
discharge 6 mo |
Normal thyroid |
et al [25] |
arteries |
angiotensin receptor blocker |
function |
Abbreviations: TSH, thyroid-stimulating hormone; Free T3, free triiodothyronine; Free T4, free thyroxine; M, male; LAD, left anterior descending coronary artery; NA, not available or not mentioned; F, female; AF, atrial fibrillation; PST, Paroxysmal supraventricular tachycardia; LM, left main coronary artery; LCX, left circumflex coronary artery; RCA, right coronary artery.
W. Zheng et al. / American Journal of Emergency Medicine 33 (2015) 983.e5–983.e10
983.e9
983.e10 W. Zheng et al. / American Journal of Emergency Medicine 33 (2015) 983.e5–983.e10
References
- Zheng Y, Shen BT, Dai YM, Zhao XZ, Zheng Y, Zhao W. Acute myocardial infarc- tion associated with painless thyroiditis. Am J Med Sci 2014;348(3):266-7. http://dx.doi.org/10.1097/maj.0000000000000309 [published Online First: Epub Date].
- Bouabdallaoui N, Mouquet F, Ennezat PV. Acute myocardial infarction with normal coronary arteries associated with Subclinical Graves disease. Am J Emerg Med 2013;31(12):1721.e1-2. http://dx.doi.org/10.1016/j.ajem.2013.07.023 [published Online First: Epub Date].
- Kim HJ, Jung TS, Hahm JR, Hwang SJ, Lee SM, Jung JH, et al. Thyrotoxicosis- induced acute myocardial infarction due to painless thyroiditis. Thyroid 2011; 21(10):1149-51. http://dx.doi.org/10.1089/thy.2010.0428 [published Online First: Epub Date].
- Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344(7):501-9. http://dx.doi.org/10.1056/NEJM200102153440707 [published Online First: Epub Date].
- Grais IM, Sowers JR. Thyroid and the heart. Am J Med 2014;127(8):691-8. http://dx. doi.org/10.1016/j.amjmed.2014.03.009 [published Online First: Epub Date].
- Schwartz F, Bergmann N, Zerahn B, Faber J. Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies. Scand J Clin Lab Invest 2013;73(3):240-4. http://dx.doi.org/ 10.3109/00365513.2013.769623 [published Online First: Epub Date].
- Vitug AC, Goldman JM. Silent (painless) thyroiditis. Evidence of a geographic varia- tion in frequency. Arch Intern Med 1985;145(3):473-5.
- Hiraiwa T, Tsujimoto N, Tanimoto K, Terasaki J, Amino N, Hanafusa T. Use of Color Doppler ultrasonography to measure thyroid blood flow and differentiate Graves’ disease from painless thyroiditis. Eur Thyroid J 2013;2(2):120-6. http://dx.doi.org/ 10.1159/000350560 [published Online First: Epub Date].
- Intenzo CM, Capuzzi DM, Jabbour S, Kim SM, dePapp AE. Scintigraphic fea- tures of autoimmune thyroiditis. Radiographics 2001;21(4):957-64. http:// dx.doi.org/10.1148/radiographics.21.4.g01jl17957 [published Online First: Epub Date].
- Patane S, Marte F, Sturiale M. Acute myocardial infarction without significant coro- nary stenoses associated with endogenous subclinical hyperthyroidism. Int J Cardiol 2012;156(1):e1-3. http://dx.doi.org/10.1016/j.ijcard.2009.12.014 [published Online First: Epub Date].
- Lee CP, Lee WL, Lai HC, Ting CT, Wang KY, Liu TJ. Recurrent vasodilator-refractory acute coronary syndrome as the exclusive manifestation of Graves disease. Am J Emerg Med 2012;30(8):1656 e5-9. http://dx.doi.org/10.1016/j.ajem.2011.07.026 [published Online First: Epub Date].
- Kauffels A, Lee IO, Schilling MK, Slotta JE. Thyrotoxicosis after parathyroidectomy mimicking myocardial infarction: a case report and review of the literature. Clin Res Cardiol 2012;101(8):687-90. http://dx.doi.org/10.1007/s00392-012-0446-0 [published Online First: Epub Date].
- Hama M, Abe M, Kawaguchi T, et al. A case of myocardial infarction in a young female with subclinical hyperthyroidism. Int J Cardiol 2012;158(2):e23-5. http:// dx.doi.org/10.1016/j.ijcard.2011.10.038 [published Online First: Epub Date].
- Patane S, Marte F. Paroxysmal atrial fibrillation during acute myocardial infarction associated with subclinical hyperthyroidism, severe three vessels coronary artery disease and elevation of prostate-specific antigen after TURP. Int J Cardiol 2010; 138(2):e28-30. http://dx.doi.org/10.1016/j.ijcard.2008.06.040 [published Online First: Epub Date].
- Lewandowski KC, Rechcinski T, Krzeminska-Pakula M, Lewinski A. Acute myocardial infarction as the first presentation of thyrotoxicosis in a 31-year old woman – case report. Thy Res 2010;3(1). http://dx.doi.org/10.1186/1756-6614-3-1 [published Online First: Epub Date].
- Patane S, Marte F. Paroxysmal ventricular tachycardia and paroxysmal atrial fibrilla- tion associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2010; 138(3):e44-6. http://dx.doi.org/10.1016/j.ijcard.2008.06.062 [published Online First: Epub Date].
- Patane S, Marte F. Atrial fibrillation and acute myocardial infarction without significant coronary stenoses associated with subclinical hyperthyroidism and erythrocytosis. Int J Cardiol 2010;145(1):e36-9. http://dx.doi.org/10.1016/j.ijcard.2008.12.135 [published Online First: Epub Date].
- Iwanczuk W. Myocardial infarction and shock associated with thyrotoxicosis. Anestezjol Intens Ter 2010;42(3):142-6.
- Patane S, Marte F, Patane F, Di Bella G, Chiofalo S, Cinnirella G, et al. Acute myocardial infarction in a young patient with myocardial bridge and elevated levels of free triiodothyronine. Int J Cardiol 2009;132(1):140-2. http://dx.doi.org/10.1016/j. ijcard.2007.07.153 [published Online First: Epub Date].
- Patane S, Marte F, Di Bella G, Turiano G. Acute myocardial infarction and subclinical hy- perthyroidism without significant coronary stenoses. Int J Cardiol 2009;134(3):e135-7. http://dx.doi.org/10.1016/j.ijcard.2008.03.011 [published Online First: Epub Date].
- Patel R, Peterson G, Rohatgi A, Ghayee HK, Keeley EC, Auchus RJ, et al. Hyperthyroidism- associated coronary vasospasm with myocardial infarction and subsequent euthyroid angina. Thyroid 2008;18(2):273-6. http://dx.doi.org/10.1089/thy.2007.0131 [pub- lished Online First: Epub Date].
- Chudleigh RA, Davies JS. Graves’ thyrotoxicosis and coronary artery spasm. Postgrad Med J 2007;83(985):e1-2. http://dx.doi.org/10.1136/pgmj.2007.062299 [published Online First: Epub Date].
- Gowda RM, Khan IA, Soodini G, Vasavada BC, Sacchi TJ. Acute myocardial infarction with normal coronary arteries associated with iatrogenic hyperthyroidism. Int J Cardiol 2003;90(2-3):327-9.
- Lassnig E, Berent R, Auer J, Eber B. Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism. Int J Cardiol 2003;90(2-3):333-5.
- Timurkaynak T, Aydogdu G, Cengel A. Acute myocardial infarction secondary to thyrotoxicosis. Acta Cardiol 2002;57(6):439-42.